2016 Pharmaceutical Companies Vaccines 
pharmaphorum
MAY 26, 2021
The government’s last attempt to shake up patient data-sharing – 2013’s Care.data scheme – suffered from a number of false starts and was eventually shut down in 2016. Its demise came after the Caldicott review into safeguards found issues with consent and opt-out processes. We truly hope it won’t be necessary to litigate.
pharmaphorum
SEPTEMBER 18, 2020
But although it was dubbed a “dangerous game”, some companies came out on top… On 6th April 1999, two companies with similar science-based cultures and a shared vision of the pharmaceutical industry came together to form what’s now considered as one of the top ten pharma companies in the world: AstraZeneca.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
pharmaphorum
APRIL 11, 2022
Medicines and vaccines are among the most powerful interventions that can help improve quality of life for people across the world. At Janssen, we strive to improve access to our innovative medicines and vaccines and achieve the best possible outcomes for patients across the world. About the author.
pharmaphorum
JANUARY 9, 2023
1 Kenya, for example, entered the pandemic with no human vaccines manufacturing facility and established the BioVax institute for local vaccine manufacture with a major plant investment starting in 2023. More remains to be addressed, and not just by conventional pharmaceutical companies. Pharma boxed in?
The Checkup by Singlecare
MAY 16, 2024
You should not get live vaccines during treatment with Remicade, and other vaccines may be less effective. Inflectra Approved by the FDA in 2016, Inflectra (infliximab-dyyb) was the first biosimilar to Remicade. The pharmaceutical company Janssen produces both Remicade and unbranded infliximab.
Roots Analysis
FEBRUARY 26, 2024
Given the robust pipeline of biologics, which include monoclonal antibodies, vaccines and other protein-based therapeutic products, subcutaneous medications are being investigated for various clinical candidates across different phases of development.
pharmaphorum
DECEMBER 2, 2020
Since the turn of the millennium, Pfizer has embarked on a series of mega-mergers, gobbling up Warner-Lambert in 2000, Pharmacia and Upjohn in 2002, Wyeth in 2009, and Medivation in 2016. In 2014 the company made an offer of around $100 billion to acquire UK firm AstraZeneca (which at the time was going through a rough patch ).
Expert insights. Personalized for you.
116 
Let's personalize your content